Moving beyond access: Towards a quality-orientated substance abuse treatment system in South Africa

There is growing concern about the increased demand for and limited access to substance abuse treatment in South Africa. The government has responded by allocating more money to the delivery of substance abuse treatment, expanding the number of state-funded treatment slots, and training additional health and social workers to deliver these services, particularly in provinces where the prevalence of substance-related problems is high, such as the Western Cape. While these efforts should be commended and continued, steps to improve service availability have occurred without adequate consideration of the quality of services provided. This is not surprising, as there is little or no routine monitoring and evaluation of substance abuse services in the country. It is also disquieting, as access to treatment is necessary but not sufficient for positive treatment outcomes

A possible sub-kiloparsec dual AGN buried behind the galaxy curtain

Although thousands of galaxy mergers are known, only a handful of sub-kiloparsec-scale supermassive black hole (SMBH) pairs have been confirmed so far, leaving a huge gap between the observed and predicted numbers of such objects. In this work, we present a detailed analysis of the Sloan Digital Sky Survey optical spectrum and of near-infrared (NIR) diffraction limited imaging of SDSS J1431+4358. This object is a local radio-quiet type 2 active galactic nucleus (AGN) previously selected as a double AGN candidate on the basis of the double-peaked [OIII] emission line. The NIR adaptive optics-assisted observations were obtained at the Large Binocular Telescope with the LUCI+FLAO camera. We found that most of the prominent optical emission lines are characterized by a double-peaked profile, mainly produced by AGN photoionization. Our spectroscopical analysis disfavors the hypothesis that the double-peaked emission lines in the source are the signatures of outflow kinematics, leaving open the possibility that we are detecting either the rotation of a single narrow-line region or the presence of two SMBHs orbiting around a common central potential. The latter scenario is further supported by the high-spatial resolution NIR imaging: After subtracting the dominant contribution of the stellar bulge component in the host galaxy, we detect two faint nuclear sources at r < 0.5 kpc projected separation. Interestingly, the two sources have a position angle consistent with that defined by the two regions where the [OIII] double peaks most likely originate. Aside from the discovery of a promising sub-kiloparsec scale dual AGN, our analysis shows the importance of an appropriate host galaxy subtraction in order to achieve a reliable estimate of the incidence of dual AGNs at small projected separations

Dysplastic Ichthyosis Uteri-like changes of the entire endometrium associated with a squamous cell carcinoma of the uterine cervix

Ichthyosis uteri is an exceedingly rare condition in which the entire surface of the endometrium is replaced by stratified squamous epithelium. Originally described as an endometrial response to iatrogenically-introduced caustic substances, similar changes have since been described in association with a variety of inflammatory conditions of the endometrium. We describe herein a heretofore undescribed example of a moderately differentiated squamous cell carcinoma of the uterine cervix associated with extensive ichthyosis uteri-like changes of the entire adjacent endometrium. Additionally, the squamous epithelium of the latter also showed multifocal changes diagnostic of a low-grade squamous intraepithelial lesion. The potential genesis of this composite of findings is discussed, as is the neoplastic potential of ichthyosis uteri. It is concluded that a squamous cell carcinoma of the cervix extended proximally into the endometrium, and that there was a colonization of a pre-existing ichthyosis uteri by associated human papillomavirus. The possibility of significant cervical pathology should be considered when plaques of squamous epithelium with low grade dysplastic changes are identified in an endometrial biopsy or curettage

Surgical site infection after caesarean section. Space for post-discharge surveillance improvements and reliable comparisons

Surgical site infections (SSI) after caesarean section (CS) represent a substantial health system concern. Surveying SSI has been associated with a reduction in SSI incidence. We report the findings of three (2008, 2011 and 2013) regional active SSI surveillances after CS in community hospital of the Latium region determining the incidence of SSI. Each CS was surveyed for SSI occurrence by trained staff up to 30 post-operative days, and association of SSI with relevant characteristics was assessed using binomial logistic regression. A total of 3,685 CS were included in the study. A complete 30 day post-operation follow-up was achieved in over 94% of procedures. Overall 145 SSI were observed (3.9% cumulative incidence) of which 131 (90.3%) were superficial and 14 (9.7%) complex (deep or organ/space) SSI; overall 129 SSI (of which 89.9% superficial) were diagnosed post-discharge. Only higher NNIS score was significantly associated with SSI occurrence in the regression analysis. Our work provides the first regional data on CS-associated SSI incidence, highlighting the need for a post-discharge surveillance which should assure 30 days post-operation to not miss data on complex SSI, as well as being less labour intensive

Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan

Classifying endometrial hyperplasia (EH) according to the severity of glandular crowding (simple hyperplasia (SH) vs complex hyperplasia (CH)) and nuclear atypia (simple atypical hyperplasia (SAH) vs complex atypical hyperplasia (CAH)) should predict subsequent endometrial carcinoma risk, but data on progression are lacking. Our nested case–control study of EH progression included 138 cases, who were diagnosed with EH and then with carcinoma (1970–2003) at least 1 year (median, 6.5 years) later, and 241 controls, who were individually matched on age, date, and follow-up duration and counter-matched on EH classification. After centralised pathology panel and medical record review, we generated rate ratios (RRs) and 95% confidence intervals (CIs), adjusted for treatment and repeat biopsies. With disordered proliferative endometrium (DPEM) as the referent, AH significantly increased carcinoma risk (RR=14, 95% CI, 5–38). Risk was highest 1–5 years after AH (RR=48, 95% CI, 8–294), but remained elevated 5 or more years after AH (RR=3.5, 95% CI, 1.0–9.6). Progression risks for SH (RR=2.0, 95% CI, 0.9–4.5) and CH (RR=2.8, 95% CI, 1.0–7.9) were substantially lower and only slightly higher than the progression risk for DPEM. The higher progression risks for AH could foster management guidelines based on markedly different progression risks for atypical vs non-atypical EH

Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma*

BACKGROUND: Distinguishing endocervical adenocarcinoma (ECA) from endometrial mucinous adenocarcinoma (EMMA) is clinically significant in view of the differences in their management and prognosis. In this study, we used a panel of tumor markers to determine their ability to distinguish between primary endocervical adenocarcinoma and primary endometrial mucinous adenocarcinoma. METHODS: Immunohistochemistry using monoclonal antibodies to MUC1 (Ma695), p16, estrogen receptor (ER), progesterone receptor (PR), and vimentin, was performed to examine 32 cases, including 18 EMMAs and 14 ECAs. For MUC1, cases were scored based on the percentage of staining pattern, apical, apical and cytoplasmic (A/C), or negative. For p16, cases were scored based on the percentage of cells stained. For the rest of the antibodies, semiquantitative scoring system was carried out. RESULTS: For MUC1, majority of EMMA (14 of 18 cases, 78%) showed A/C staining, whereas only few ECA (2 of 14, 14%) were positive. The difference of MUC1 expression in the two groups of malignancy was statistically significant (p < 0.001). Staining for p16 was positive in 10 of 14 (71%) ECA and 4 of 18 (22%) EMMA. Estrogen receptor was positive in 3 of 14 (21%) ECA and 17 of 18 (94%) EMMA. Progesterone receptor was positive in 3 of 14 (21%) ECA and 16 of 18 (89%) EMMA. Vimentin was positive in 1 of 14 (7%) ECA, and 9 of 18 (50%) EMA, with median and range of 0 (0–6), and 1.5 (0–9) respectively. CONCLUSION: A panel of immunohistochemical markers including MUC1, p16, ER, PR, and vimentin is recommended, when there is morphological and clinical doubt as to the primary site of endocervical or endometrial origin

Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections

Contains fulltext : 144469.pdf (publisher's version ) (Closed access)The frequency of high-risk human papillomavirus (hr-HPV) genotypes in patients with adenocarcinoma in situ (ACIS) with coexisting cervical intraepithelial neoplasia (CIN), ACIS without coexisting CIN, and high-grade CIN (CIN II/III) was studied, in order to gain more insight into the relation between hr-HPV infections and the development of coexisting squamous and glandular lesions. The SPF(10) LiPA PCR was used to detect simultaneously 25 different HPV genotypes in biopsies obtained from 90 patients with CIN II/III, 47 patients with ACIS without coexisting CIN, and 49 patients with ACIS and coexisting CIN. hr-HPV was detected in 84 patients (93%) with CIN II/III, 38 patients (81%) with ACIS without CIN, and in 47 patients (96%) with ACIS and coexisting CIN. A total of 13 different hr-HPV genotypes were detected in patients with CIN II/III, and only five in patients with ACIS with/without coexisting CIN. HPV 31, multiple hr-HPV genotypes, and HPV genotypes other than 16, 18, and 45 were significantly more often detected in patients with CIN II/III, while HPV 18 was significantly more often detected in patients with ACIS with/without CIN. There were no significant differences in the frequency of specific hr-HPV genotypes between patients with ACIS with or without coexisting CIN. In conclusion, the frequency of specific hr-HPV genotypes is similar for patients with ACIS without CIN and patients with ACIS and coexisting CIN, but is significantly different for patients with CIN II/III without ACIS. These findings suggest that squamous lesions, coexisting with high-grade glandular lesions, are aetiologically different from squamous lesions without coexisting glandular lesions

Advancing Field-Based GNSS Surveying for Validation of Remotely Sensed Water Surface Elevation Products

To advance monitoring of surface water resources, new remote sensing technologies including the forthcoming Surface Water and Ocean Topography (SWOT) satellite (expected launch 2022) and its experimental airborne prototype AirSWOT are being developed to repeatedly map water surface elevation (WSE) and slope (WSS) of the world’s rivers, lakes, and reservoirs. However, the vertical accuracies of these novel technologies are largely unverified; thus, standard and repeatable field procedures to validate remotely sensed WSE and WSS are needed. To that end, we designed, engineered, and operationalized a Water Surface Profiler (WaSP) system that efficiently and accurately surveys WSE and WSS in a variety of surface water environments using Global Navigation Satellite Systems (GNSS) time-averaged measurements with Precise Point Positioning corrections. Here, we present WaSP construction, deployment, and a data processing workflow. We demonstrate WaSP data collections from repeat field deployments in the North Saskatchewan River and three prairie pothole lakes near Saskatoon, Saskatchewan, Canada. We find that WaSP reproducibly measures WSE and WSS with vertical accuracies similar to standard field survey methods [WSE root mean squared difference (RMSD) ∼8 cm, WSS RMSD ∼1.3 cm/km] and that repeat WaSP deployments accurately quantify water level changes (RMSD ∼3 cm). Collectively, these results suggest that WaSP is an easily deployed, self-contained system with sufficient accuracy for validating the decimeter-level expected accuracies of SWOT and AirSWOT. We conclude by discussing the utility of WaSP for validating airborne and spaceborne WSE mappings, present 63 WaSP in situ lake WSE measurements collected in support of NASA’s Arctic-Boreal and Vulnerability Experiment, highlight routine deployment in support of the Lake Observation by Citizen Scientists and Satellites project, and explore WaSP utility for validating a novel GNSS interferometric reflectometry LArge Wave Warning System